Antiphospholipid Syndrome
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Antiphospholipid Syndrome

What is the definition of Antiphospholipid Syndrome?

Antiphospholipid syndrome is a disorder characterized by an increased tendency to form abnormal blood clots (thromboses) that can block blood vessels. This clotting tendency is known as thrombophilia. In antiphospholipid syndrome, the thromboses can develop in nearly any blood vessel in the body. If a blood clot forms in the vessels in the brain, blood flow is impaired and can lead to stroke. Antiphospholipid syndrome is an autoimmune disorder. Autoimmune disorders occur when the immune system attacks the body's own tissues and organs.

What are the causes of Antiphospholipid Syndrome?

The genetic cause of antiphospholipid syndrome is unknown. This condition results from the presence of three abnormal immune proteins (antibodies) in the blood. The antibodies that cause antiphospholipid syndrome are called lupus anticoagulant, anticardiolipin, and anti-B2 glycoprotein I. These antibodies are referred to as antiphospholipid antibodies. People with this condition can test positive for one, two, or all three antiphospholipid antibodies in their blood. Antibodies normally attach (bind) to specific foreign particles and germs, marking them for destruction, but the antibodies in antiphospholipid syndrome attack normal human proteins. When these antibodies attach to proteins, the proteins change shape and attach to other molecules and receptors on the surface of cells. Attaching to cells, particularly immune cells, turns on (activates) the blood clotting pathway and other immune responses.

How prevalent is Antiphospholipid Syndrome?

Antiphospholipid syndrome is estimated to affect 1 in 2,000 people. This condition may be responsible for up to one percent of all thromboses. It is estimated that 20 percent of individuals younger than age 50 who have a stroke have antiphospholipid syndrome. Ten to 15 percent of people with systemic lupus erythematosus have antiphospholipid syndrome. Similarly, 10 to 15 percent of women with recurrent miscarriages likely have this condition. Approximately 70 percent of individuals diagnosed with antiphospholipid syndrome are female.

Is Antiphospholipid Syndrome an inherited disorder?

Most cases of antiphospholipid syndrome are sporadic, which means they occur in people with no history of the disorder in their family. Rarely, the condition has been reported to run in families; however, it does not have a clear pattern of inheritance. Multiple genetic and environmental factors likely play a part in determining the risk of developing antiphospholipid syndrome.

Who are the top Antiphospholipid Syndrome Local Doctors?
Elite in Antiphospholipid Syndrome
Elite in Antiphospholipid Syndrome
Referral required

Duke Hematology Clinic - Clinic 1E

40 Duke Medicine Cir, 
Durham, NC 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Thomas Ortel is a Hematologist practicing medicine in Durham, North Carolina. Dr. Ortel is rated as an Elite provider by MediFind in the treatment of Antiphospholipid Syndrome. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Venous Thromboembolism (VTE), Antiphospholipid Syndrome, Thrombocytopenia, Thrombectomy, and Thalamotomy. Dr. Ortel is board certified in American Board Of Internal Med, Hematology and American Board Of Internal Med, Internal Medicine. Dr. Ortel is currently accepting new patients.

Elite in Antiphospholipid Syndrome
Rheumatology
Elite in Antiphospholipid Syndrome
Rheumatology
Referral may be required

Taubman Center

1500 E Medical Center Dr, Floor 3 Reception A, 
Ann Arbor, MI 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Jason Knight is a Rheumatologist practicing medicine in Ann Arbor, Michigan. Dr. Knight is rated as an Elite provider by MediFind in the treatment of Antiphospholipid Syndrome. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Antiphospholipid Syndrome, Systemic Lupus Erythematosus (SLE), Takayasu Arteritis, and Granulomatosis with Polyangiitis. Dr. Knight is board certified in Rheumatology. Dr. Knight is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Antiphospholipid Syndrome
Elite in Antiphospholipid Syndrome
Referral may be required

Cleveland Clinic Main Campus

10201 Carnegie Avenue, 
Cleveland, OH 
Experience:
44+ years
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Keith Mccrae is a Hematologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 44 years. Dr. Mccrae is rated as an Elite provider by MediFind in the treatment of Antiphospholipid Syndrome. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Antiphospholipid Syndrome, Venous Thromboembolism (VTE), Hereditary Hemorrhagic Telangiectasia, Thrombocytopenia, and Splenectomy. Dr. Mccrae is board certified in American Board Of Internal Medicine, 1988. Dr. Mccrae is currently accepting new patients.

What are the latest Antiphospholipid Syndrome Clinical Trials?
Thrombocytopenia Trajectories as a Dynamic Biomarker of Clinical Severity and Survival in Antiphospholipid Syndrome: A Multicenter Cohort Study

Summary: Thrombocytopenia is common in antiphospholipid syndrome (APS) and is now included in the 2023 ACR/EULAR APS criteria as an important non criteria/hematologic feature. Persistent or low-moderate thrombocytopenia independently predicts reduced long-term survival in APS, with hazard ratios for mortality around 2.7-4.4, and is associated with a severe disease phenotype and thrombotic deaths.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Follow-up Cohort of Patients With Antiphospholipid Syndrome

Summary: Antiphospholipid syndrome (APLS) is a rare pathology characterized by the association of thrombotic (arterial, venous) or obstetric clinical manifestations and the persistent presence at least twelve weeks apart of antiphospholipid antibodies (APL). It is also accompanied by accelerated atherosclerosis responsible for an increased incidence of myocardial infarction, peripheral arterial disease and...

Who are the sources who wrote this article ?

Published Date: July 11, 2022
Published By: National Institutes of Health